Medical Xpress on MSN8d
Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer: StudyAdding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...
Announced positive preliminary 12-week clinical results, building on already released 4-week results, of ongoing type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplan ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several updates on the Company’s type 1 diabetes (T1D) ...
The FDA granted an orphan drug designation to PEP-010 for the treatment of patients with metastatic pancreatic cancer.
ZME Science on MSN8d
Scientists Discover Cells That Defy Death and Form New Life After the Body Dies. Enter The “Third State”Researchers have found that some cells form new multicellular structures with functions that defy their original biological ...
Health and Me on MSN13d
New Pancreatic Cancer Vaccine Could Possibly Stop Its ReturnA new pancreatic vaccine may stop the disease from returning. However, the cause of concern now is its sample size on trials ...
The AACR poster presentation will provide an update on the data in AML patients most recently presented at the American ...
Sana Biotechnology, Inc.’s SANA share price has dipped by 11.16%, which has investors questioning if this is right time to ...
Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous ...
Vertex Pharmaceuticals (VRTX) announced several updates on the company’s type 1 diabetes portfolio. Vertex has completed enrollment and dosing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback